logo
Karnataka Bank's chief assures stability, growth

Karnataka Bank's chief assures stability, growth

Time of India16-07-2025
Mangaluru: Raghavendra S Bhat took charge as the new MD & CEO of Karnataka Bank at its corporate headquarters in Mangaluru on Wednesday. Addressing recent concerns, Bhat assured customers that the bank remains fundamentally strong.
He told reporters, "Karnataka Bank has consistently maintained profitability and declared dividends since its inception, which is unique in the Indian banking sector."
O
utlining his vision, Bhat said his immediate goal is to increase the bank's business turnover from Rs 1.8 lakh crore to Rs 2 lakh crore. "I am committed to taking every necessary step in the best interest of the bank and its stakeholders," he said.
Dismissing speculation, Bhat firmly ruled out any plans to shift the bank's headquarters from Mangaluru or to change its name. "We are proud of our strong regional roots and legacy," he affirmed.
With a career at Karnataka Bank spanning nearly four decades, Bhat began as a clerk in 1981 and rose through the ranks to become chief general manager and chief operating officer before retiring in 2019. "It is a matter of great pride and joy to return to the institution that shaped my professional journey. However, the post comes with a lot of responsibility," he said.
Bhat called for collective support from employees and customers and assured that the vision of supporting agriculture, MSMEs and other sectors will continue.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

No Entry For GM Crops, Says New Delhi; India-US Trade Talks Hit A Sacred Wall
No Entry For GM Crops, Says New Delhi; India-US Trade Talks Hit A Sacred Wall

India.com

time35 minutes ago

  • India.com

No Entry For GM Crops, Says New Delhi; India-US Trade Talks Hit A Sacred Wall

New Delhi: Genetically modified (GM) crops will not be crossing India's borders anytime soon, no matter how urgently the United States knocks. As trade negotiations between New Delhi and Washington enter a crucial phase, insiders say one red line is not up for discussion. 'There are things that are not about negotiation. Some things are a matter of principle,' said a senior official close to the development. That principle, sources say, is GM corn and soy. While American negotiators have made agricultural access a central demand, pressing India for a wider entry gate for U.S. farm goods, New Delhi is not blinking, especially on GM imports. Over the years, the issue has mutated from a mere trade disagreement into a symbolic fight over sovereignty, food safety and grassroots politics. The United States Trade Representative (USTR) has repeatedly flagged India's restrictions on GM products, calling them 'non-tariff barriers'. But Indian authorities remain unmoved, largely because of the hardline stance taken by domestic groups closely aligned with the ruling establishment. Last month, the message from Sangh affiliates was if America insists on forcing GM crops into the Indian market, there may be no trade deal at all. Carried in Business Standard, that warning echoed the sentiments of influential groups such as the Bharatiya Kisan Sangh (BKS) and the Swadeshi Jagran Manch (SJM), which have long opposed agricultural concessions to Washington, particularly in sectors like dairy and GM crops. Their argument? Food security. The BKS has often warned that allowing U.S. crops into India, especially without clear labelling or transparency, could sabotage domestic farming ecosystems and compromise health safety standards. On the other hand, the SJM sees this as a direct attack on economic self-reliance. Meanwhile, the clock is ticking. U.S. officials have privately hinted at the urgency of the moment, pointing to a deadline set by President Donald Trump, who is seeking a revival of his trade agenda. Trump has marked August 1 as a red-letter day. If no interim deal is inked by then, India could be hit with reciprocal tariffs, potentially as high as 26 percent. Indian trade negotiators are not indifferent to that pressure. But according to officials involved in the process, the sixth round of talks will only happen in the second half of August after Trump's deadline expires. Any hope for a short-term resolution seems, at best, unrealistic. As one official put it, 'We are not looking at compromise in areas that touch the lives of millions.' In other words, GM corn is off the table. And perhaps, so is the deal, at least for now.

Lenskart receives shareholder nod to raise ₹2,150 crore via IPO: Report
Lenskart receives shareholder nod to raise ₹2,150 crore via IPO: Report

Mint

time2 hours ago

  • Mint

Lenskart receives shareholder nod to raise ₹2,150 crore via IPO: Report

Lenskart IPO: Peyush Bansal-led Indian eyewear company Lenskart has received the approval of its shareholder to raise ₹ 2,150 crore through a fresh issue of shares, reported MoneyControl, citing people aware of the development. According to news report, the company filed its corporate action development with the Ministry of Corporate Affairs' (MCA) Registrar of Companies (RoC), as per the data accessed by TheKredible. The proposal to raise money via an IPO was reportedly given the green light at the company's annual general meeting on 26 July 2025, said the report, adding, the eyewear company is expected to file its draft red herring prospectus (DRHP) with the capital markets regulator, the Securities and Exchange Board of India (Sebi), in the upcoming days. The overall IPO size is expected to be around $1 billion or ₹ 8,500 crore, which includes a secondary offer-for-sale (OFS) component by the existing investors, the report added. Earlier this month, Mint reported that the eyewear company's founder, Peyush Bansal, is looking to buy a 1.5-2% stake in the eyewear retailer worth about $150 million from existing investors ahead of its planned IPO. Peyush is buying small stakes from a bunch of investors. This is being negotiated at around $7-8 billion valuation. Existing investors like TR Capital, Chiratae, Softbank and Kedaara Capital are expected to sell their stake as part of the deal. Over the years, the company has raised $1.08 billion in funding across 19 rounds, including its latest Series I round for $18.2 million on 21 July 2023. It has received investments from various firms, including SoftBank Vision Fund, TPG, and Chiratae Ventures. Kotak Mahindra Capital, Axis Capital, Citi, Morgan Stanley, and Avendus Capital are the company-appointed book-runners for the IPO, which is soon expected to hit Dalal Street. The company was founded in 2010, and since then, it has emerged as one of the biggest players in the Indian eyewear industry. It has 2500 retail outlets across the nation and a presence globally, such as in Singapore and the United Arab Emirates (UAE).

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store